Testosterone Replacement Therapy Monitoring

Introduction to Monitoring

• Testosterone levels should be measured 2-3 months after initiating topical testosterone therapy or after any dose change, and then every 6-12 months once stable levels are achieved, as recommended by the American College of Gastroenterology and the American Urological Association 1, 2

Monitoring Frequency and Timing

• The first measurement of testosterone levels should be taken 2-3 months after starting therapy, and follow-up measurements should be taken at 6-12 month intervals once stable levels are achieved, with additional testing after any dose adjustment 1, 2
• Blood samples for testosterone level measurement should be drawn in the morning between 8 AM and 10 AM for the most accurate results, while for patients using transdermal preparations, levels can be measured at any time, though peak values occur 6-8 hours after application 1

Target Testosterone Levels and Dose Adjustments

• The goal of monitoring is to ensure testosterone levels reach and maintain the mid-normal range (approximately 450-600 ng/dL), with dose adjustments following a specific algorithm:

Comprehensive Monitoring Parameters

• Beyond testosterone levels, the following should be monitored: prostate-specific antigen (PSA) to detect potential prostate issues, hemoglobin/hematocrit to detect polycythemia, liver function tests to monitor hepatic effects, and lipid profile to assess cardiovascular risk 1, 2

Discontinuation of Therapy

• If target testosterone levels are achieved but symptoms persist after 3-6 months, consideration should be given to discontinuing therapy, as recommended by the American Urological Association 2